D-1025-2018 Class II Terminated

Recalled by West-Ward Columbus Inc — Columbus, OH

FDA drug recall D-1025-2018 was initiated by West-Ward Columbus Inc on Jul 24, 2018 and is designated Class II. Reason for recall: Failed Dissolution Specifications: The recall status is terminated (terminated Apr 29, 2020). Affected quantity: 29048 500-count bottles (14,524,000 tablets).

Recall details

Product Type
Drugs
Report Date
Aug 8, 2018
Initiation Date
Jul 24, 2018
Termination Date
Apr 29, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29048 500-count bottles (14,524,000 tablets)

Product description

Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-05.

Reason for recall

Failed Dissolution Specifications:

Distribution pattern

Nationwide in the USA.

Code information

Lot# 71545A, Expiry date: 07/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1025-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1025-2018. Report a data issue: hello@regdatalab.com.